[
  {
    "headline": "Regeneron Pharmaceuticals' (NASDAQ:REGN) earnings growth rate lags the 11% CAGR delivered to shareholders",
    "url": "https://finance.yahoo.com/news/regeneron-pharmaceuticals-nasdaq-regn-earnings-140013345.html?.tsrc=rss",
    "publication_date": "2025-02-13T14:00:13.000Z",
    "full_article_text": "No content found"
  },
  {
    "headline": "Regeneron Announces Investor Conference Presentations",
    "url": "https://finance.yahoo.com/news/regeneron-announces-investor-conference-presentations-210500485.html?.tsrc=rss",
    "publication_date": "2025-02-11T21:05:00.000Z",
    "full_article_text": "No content found"
  },
  {
    "headline": "Linvoseltamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Multiple Myeloma",
    "url": "https://finance.yahoo.com/news/linvoseltamab-bla-accepted-fda-review-120000264.html?.tsrc=rss",
    "publication_date": "2025-02-11T12:00:00.000Z",
    "full_article_text": "No content found"
  }
]